Reflex Molecular Testing in Melanoma Diagnosis: When Should BRAF Mutation Testing Be Ordered and Who Should Order It?
- 8 September 2021
- journal article
- letter
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 26 (2) , 201-202
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma PatientsCancers, 2021
- Epidemiology and Survival Outcomes in Stages II and III Cutaneous Melanoma: A Systematic ReviewMelanoma Management, 2020
- Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across CanadaJournal of Cutaneous Medicine and Surgery, 2019
- Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicineCancer Treatment Reviews, 2018
- Rate of Egfr Mutation Testing for Patients with Nonsquamous Non-Small-Cell Lung Cancer with Implementation of Reflex Testing by PathologistsCurrent Oncology, 2017